GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » 5-Year Yield-on-Cost %

Mega Lifesciences PCL (BKK:MEGA-R) 5-Year Yield-on-Cost % : 15.47 (As of Jul. 17, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL 5-Year Yield-on-Cost %?

Mega Lifesciences PCL's yield on cost for the quarter that ended in Mar. 2025 was 15.47.


The historical rank and industry rank for Mega Lifesciences PCL's 5-Year Yield-on-Cost % or its related term are showing as below:

BKK:MEGA-R' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.18   Med: 6.2   Max: 16.81
Current: 15.47


During the past 13 years, Mega Lifesciences PCL's highest Yield on Cost was 16.81. The lowest was 3.18. And the median was 6.20.


BKK:MEGA-R's 5-Year Yield-on-Cost % is ranked better than
94.36% of 514 companies
in the Drug Manufacturers industry
Industry Median: 2.205 vs BKK:MEGA-R: 15.47

Competitive Comparison of Mega Lifesciences PCL's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mega Lifesciences PCL's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's 5-Year Yield-on-Cost % falls into.


;
;

Mega Lifesciences PCL 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Mega Lifesciences PCL is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Mega Lifesciences PCL  (BKK:MEGA-R) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Mega Lifesciences PCL 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Lifesciences PCL Business Description

Traded in Other Exchanges
Address
Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines